Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer

British Journal of Cancer

Volumn 101, Issue 12, 2009, Pages 1957-1960

  Tamez, S ^a   Norizoe, C ^a   Ochiai, K ^a   Takahashi, D ^a   Shimojima, A ^a   Tsutsumi, Y ^a   Yanaihara, N ^a   Tanaka, T ^a   Okamoto, A ^a   Urashima, M ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; Prognosis; Single nuclear polymorphisms; SNPs

Indexed keywords

CARBOPLATIN; PACLITAXEL; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME;

ADULT; COHORT STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 71649086565     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605414     Document Type: Article

References (17)

1. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12: 915-921
2. Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E (2008) Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 260: 209-215
3. Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhäger JC, Pols HA, van Leeuwen JP (2000) Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol 52: 211-216
4. Garland CF, Mohr SB, Gorham ED, Grant WB, Garland FC (2006) Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med 31: 512-514
5. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol May 27: 3757-3763
6. Grant WB (2006) The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival. Anticancer Res 26: 2605-2614
7. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11: 1850-1855
8. Heist RS, Zhou W, Wang Z, Liu G, Neuberg D, Su L, Asomaning K, Hollis BW, Lynch TJ, Wain JC, Giovannucci E, Christiani DC (2008) Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 26: 5596-5602
9. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266-281
10. Kikkawa F, Nawa A, Ino K, Shibata K, Kajiyama H, Nomura S (2006) Advances in treatment of epithelial ovarian cancer. Nagoya J Med Sci 68: 19-26
11. Lange TS, Stuckey AR, Robison K, Kim KK, Singh RK, Raker CA, Brard L (2009) Effect of a Vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model. Invest New Drugs 7 July 2009 [Epub ahead of print]
12. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT (2007) Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 16: 2566-2571
13. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, Fuchs CS (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 26: 2984-2991
14. Raimondi S, Johansson H, Maisonneuve P, Gandini S (2009) Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 30: 1170-1180
15. Tworoger SS, Gates MA, Lee IM, Buring JE, Titus-Ernstoff L, Cramer D, Hankinson SE (2009) Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res 69: 1885-1891
16. Zhang X, Jiang F, Li P, Li C, Ma Q, Nicosia SV, Bai W (2005) Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089. Clin Cancer Res 11: 323-328
17. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L, Christiani DC (2007) Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25: 479-485